Medical Products of Human Origin, UDI and ICCBBA: Supply Chain’s Role

By AHRMM

Some Human Cellular Tissue Products (HCTP) are considered “devices” and will require their assigned Unique Device Identifiers (UDI) to be tracked within the patient’s Electronic Health Record (EHR) and shared across the healthcare spectrum. Supply chain should be having interdepartmental conversations to determine how they will handle these types of products and their UDIs.

Related Resources

On-Demand Educational Webinars
AHRMM Data Solutions: Driving Results with Data - Hospital PMI™ and AHRMM Keys
In the first half of the webinar, we will explore the Hospital PMI™, an ISM®<
Letter/Comment
AHRMM Comment Letter to FDA RE: “Modernizing FDA’s Data Strategy”
In September 2019, FDA announced its
Press Releases
In Partnership with AHRMM, Institute for Supply Management® Expands Portfolio of Economic Reports with Launch of Hospital PMI™
CHICAGO, July 23, 2020 — In partnership with the Association for Health Care Resource & Materials Management (AHRMM) of the American Hospital A
Guides/Reports
Hospital ISM® Report On Business®
Podcasts
Inventory Method Variation During the COVID-19 Pandemic
Learn how UCHealth was able to rapidly change and improve their inventory methods throughout the COVID-19 pandemic and how you can apply these…
Podcasts
Forming a Medical Logistics Crisis Action Team (MEDLOG CAT)
Discover how a Medical Logistics Crisis Action Team could help your institution quickly organize efforts and resources in addition to your Incident…